Physician profile
Perinchery Narayan
NPI 1083635494
$1,260.69
in general payments reported to CMS, 2019-2025
26 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.05 · 2020: $33.75 · 2021: $444 · 2022: $170 · 2023: $72.35 · 2024: $91.83 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $236.56 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $132.08 | 2019-2024 | Spaceoar Vue System - 10ml |
| Coloplast Corp | $108.13 | 2021-2022 | |
| Astellas Pharma US INC | $86.76 | 2021-2022 | |
| Urogen Pharma, INC. | $85.75 | 2022-2025 | Jelmyto |
| Axonics, INC. | $63.52 | 2021 | |
| Agiliti Surgical, INC. | $54.53 | 2021 | |
| Teleflex LLC | $45.92 | 2021-2025 | Barrigel |
| Olympus America INC. | $43.11 | 2021-2023 | Itind System |
| Endo Pharmaceuticals INC. | $41.79 | 2021-2023 | Xiaflex |
| Myovant Sciences INC. | $40.85 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $33.75 | 2020 | |
| Profound Medical Corp. | $33.12 | 2022-2025 | Tulsa-Pro |
| Medtronic, INC. | $32.49 | 2022-2025 | Interstim |
| Endo USA, INC. | $28.69 | 2025 | Xiaflex |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abc Home Medical Supply, INC. | $26.13 | 2025 | |
| Pfizer INC. | $24.52 | 2025 | |
| Urovant Sciences INC | $23.88 | 2022 | |
| Merck Sharp & Dohme LLC | $21.80 | 2022 | |
| Accord Healthcare, INC. | $19.41 | 2023 | |
| Innovation Technologies INC | $17.14 | 2025 | Irrisept |
| Metuchen Pharmaceuticals | $13.18 | 2019 | |
| Biocompatibles, INC. | $12.65 | 2019 | |
| Allergan, INC. | $11.68 | 2019 | |
| Janssen Biotech, INC. | $11.65 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perinchery Narayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.